Logo image of ATXS

ASTRIA THERAPEUTICS INC (ATXS) Stock Analyst Earnings Estimates

NASDAQ:ATXS - Nasdaq - US04635X1028 - Common Stock - Currency: USD

6.19  -0.23 (-3.58%)

After market: 6.19 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ATXS revenue by date.ATXS revenue by date.
500K
-100.00%
849.997K5.083M
498.00%
88.084M
1,632.91%
339.48M
285.40%
569.07M
67.63%
753.74M
32.45%
945.51M
25.44%
EBITDA
YoY % growth
ATXS ebitda by date.ATXS ebitda by date.
-31.46M
-46.80%
-35.16M
-11.76%
-26.79M
23.81%
N/A
2.02%
N/A
-3.09%
-35.904M
-32.68%
-197.982M
-451.42%
-52.938M
73.26%
-71.298M
-34.68%
-114.24M
-60.23%
-126.582M
-10.80%
-141.576M
-11.85%
-153.816M
-8.65%
-157.59M
-2.45%
N/AN/AN/AN/A
EBIT
YoY % growth
ATXS ebit by date.ATXS ebit by date.
-31.66M
-46.03%
-35.56M
-12.32%
-27.09M
23.82%
-27.475M
2.66%
-28.27M
-2.73%
-38.148M
-38.21%
-197.657M
-420.78%
-54M
72.56%
-80.417M
-55.20%
-114.189M
-37.53%
-129.941M
-13.79%
-147.016M
-13.14%
-166.913M
-13.53%
-112.32M
32.71%
58.499M
152.08%
197.53M
237.66%
307.02M
55.43%
447.11M
45.63%
Operating Margin
ATXS operating margin by date.ATXS operating margin by date.
N/AN/A-5,418.00%N/AN/AN/AN/AN/AN/AN/AN/A-17,296.03%-3,283.76%-127.51%17.23%34.71%40.73%47.29%
EPS
YoY % growth
ATXS eps by date.ATXS eps by date.
N/A-133.80
42.05%
-76.80
42.60%
-30.15
46.09%
-14.78
65.94%
-11.51
13.62%
-39.19
-17.49%
-3.58
74.63%
-2.32
33.33%
-1.73
28.56%
-1.87
-7.96%
-1.96
-4.74%
-1.89
3.48%
-0.61
67.57%
-0.15
75.00%
0.36
333.33%
0.97
171.43%
2.35
142.11%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.46
51.01%
-0.46
-20.97%
-0.47
-9.91%
-0.48
-15.03%
-0.50
-9.04%
-0.63
-37.57%
-0.66
-40.29%
-0.69
-43.56%
-0.59
-17.81%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-30.702M
-42.65%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-30.562M
10.64%
-31.221M
-29.28%
-31.489M
-9.33%
-32.018M
-10.35%
-32.296M
-5.68%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.42
33.33%
-0.430.012.33%
Q2 2024
Q2Q % growth
-0.43
4.44%
-0.39-0.04-9.50%
Q1 2024
Q2Q % growth
-0.38
5.00%
-0.37-0.01-2.35%
Q4 2023
Q2Q % growth
-0.94
-30.56%
-0.80-0.14-18.12%
Q3 2023
Q2Q % growth
-0.63
27.59%
-0.50-0.13-27.09%
Q2 2023
Q2Q % growth
-0.45
47.67%
-0.500.059.44%
Q1 2023
Q2Q % growth
-0.40
66.10%
-0.560.1628.94%
Q4 2022
Q2Q % growth
-0.72
93.45%
-0.730.010.81%
Q3 2022
Q2Q % growth
-0.87
-42.62%
-0.940.077.09%
Q2 2022
Q2Q % growth
-0.86
31.75%
-1.040.1816.93%
Q1 2022
Q2Q % growth
-1.18
18.06%
-0.74-0.44-58.91%
Q4 2021
Q2Q % growth
-11.00
-316.67%
-0.67-10.33-1,533.99%
Q3 2021
Q2Q % growth
-0.61
81.85%
-0.790.1822.58%
Q2 2021
Q2Q % growth
-1.26
60.38%
-1.860.6032.13%
Q1 2021
Q2Q % growth
-1.44
52.00%
-0.94-0.50-53.46%
Q4 2020
Q2Q % growth
-2.64
20.00%
-2.26-0.38-16.59%
Q3 2020
Q2Q % growth
-3.36 -3.12-0.24-7.65%
Q2 2020
Q2Q % growth
-3.18
14.52%
-2.78-0.40-14.20%
Q1 2020
Q2Q % growth
-3.00
19.35%
-2.51-0.49-19.56%
Q4 2019
Q2Q % growth
-3.30 -3.760.4612.32%
Q3 2019
Q2Q % growth
-3.36 -3.890.5313.72%
Q2 2019
Q2Q % growth
-3.72 -3.71-0.01-0.19%
Q1 2019
Q2Q % growth
-3.72 -4.250.5312.54%
ATXS Yearly EPS VS EstimatesATXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ATXS Yearly Revenue VS EstimatesATXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0.11% 0.13% 0.32%
RevenueN/A N/A N/A N/A